Story
Regenxbio Stock Rises After New Director Buys Nearly $1 Million in Shares
Regenxbio Inc. (RGNX) shares climbed 5.7% in pre-market trading after a new member of its board of directors disclosed the purchase of nearly $1 million in company stock, a move investors are interpreting as a strong bullish signal.
Details of the Insider Purchase
According to disclosures, Director Gregory Austin Ciongoli purchased a total of approximately $949,381 worth of Regenxbio common stock through open-market transactions over two days. The buying activity was reported as:
- August 26: 49,196 shares at an approximate price of $9.14 per share.
- August 27: 53,407 shares at an approximate price of $9.36 per share.
The transactions took place immediately after Ciongoli was appointed to the company's board on August 25, 2026.
Market Significance and Context
AdLarge-scale insider buying, particularly from a new director with a significant financial background, is often viewed by the market as a strong indicator of confidence in a company's future prospects. Ciongoli is the Founder and Managing Partner of Adiumentum Capital Management and previously spent over 16 years at The Baupost Group.
His decision to invest a substantial sum comes after the stock had declined roughly 13% over the prior week, suggesting the director may view the shares as undervalued. The stock's pre-market rally was notable as it occurred while the broader S&P 500 was only marginally positive, indicating the move was driven by company-specific news.
Company Outlook
The vote of confidence comes as Regenxbio navigates recent challenges, including a clinical hold on its RGX-121 program which had weighed on investor sentiment. However, the company is advancing multiple late-stage programs and expects to release topline data from pivotal trials for surabgene lomparvovec in wet AMD and diabetic retinopathy in the fourth quarter of 2026. The insider purchase appears to be prompting investors to reassess the company's risk-reward profile ahead of these key clinical catalysts.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.